BioSpace News Archive

TESARO Announces U.S. FDA Approval of VARUBI IV fo

FDA

GlaxoSmithKline’s Shingrix Approved in the U.S. for Prevention of Shingles in Adults Aged 50 and Over

Shingrix is a non-live, recombinant subunit vaccine given intramuscularly in two doses.

October 20, 2017

·

6 min read

Omeros Reports Successful OMS721 Treatment of Patient With Both Stem Cell Transplant-Associated Thrombotic Microangiopathy and Graft-Versus-Host Disease

The results may expand target for Omeros’ planned phase 3 program in HCT-TMA.

October 20, 2017

·

11 min read

Business

Easton Pharmaceuticals Announces Final Payment Completing $1.3M JV Agreement With Alliance Group

Easton has advanced its final payment, completing a total payment of $1.3 Million CDN to 1124123 Ontario Limited.

October 20, 2017

·

5 min read

Drug Development

Gilead Announces Multiple Scientific Presentations Demonstrating High Cure Rates in Difficult-to-Cure HCV Patients and Improved Long-Term Bone and Renal Safety of Vemlidy in HBV Patients Switched From Viread

Gilead Sciences, Inc.today announced results from Phase II and Phase III studies of its approved medicines for chronic hepatitis C virus (HCV) and hepatitis B virus (HBV) infection.

October 20, 2017

·

15 min read

Drug Development

CStone Pharma Announces Dosing the First Patient of CS1001: China’s First Fully Human, Full-length Anti-PD-L1 Monoclonal Antibody

CStone Pharma, Ltd. announced today that the first human clinical trial of CS1001, China’s first fully human and full-length anti-PD-L1 monoclonal antibody, had successfully dosed the first patient in Beijing Cancer Hospital.

October 20, 2017

·

4 min read

Pharm Country

Monaghan Medical Corporation Receives Innovative Technology Designation from Vizient for the AEROBIKA OPEP device

Monaghan Medical Corporation announced its AEROBIKA Oscillating Positive Expiratory Pressure (OPEP) device has received a 2017 Innovative Technology designation from Vizient, Inc., the largest member-driven health care performance improvement company in the country.

October 20, 2017

·

3 min read

Deals

Vyaire Medical Takes Out Revolutionary Medical Devices for Undisclosed Sum

RMD’s main product is a complete noninvasive nasal PAP ventilation system to treat respiratory insufficiency from collapse of the airway during or after sedation, or during the intubation process.

October 20, 2017

·

2 min read

Biotech Beach

PharmaCyte Biotech to Hold Shareholder Call

PharmaCyte Biotech announced today that Chief Executive Officer Kenneth L. Waggoner will conduct a shareholder call on Wednesday, November 1, 2017, commencing at 4:30 p.m. EDT.

October 20, 2017

·

3 min read

Business

Nicox Enters Research Collaboration With Re-Vana Therapeutics on its Next Generation of Stand-Alone NO-donors in a Novel Sustained Release Ophthalmic Formulation

The deal combines Nicox’s next generation of stand-alone nitric oxide-donors with Re-Vana’s EyeLief long-acting photo-crosslinked biodegradable drug delivery platform for the reduction of intraocular pressure.

October 20, 2017

·

7 min read

Drug Development

Spineology Initiates Post-Market Lateral Interbody Fusion Study Using Novel Implant Design

Spineology Inc., the innovator in anatomy-conserving spine surgery, has announced the initiation of a prospective, post-market lateral interbody fusion study designed to evaluate patient outcomes using its FDA-cleared Duo Lumbar Interbody Fusion System.

October 20, 2017

·

2 min read